Evaluation and Correlation of Serum Fetuin-A Levels in Periodontal Health and Disease: A Clinico-biochemical Study
1 other identifier
interventional
60
1 country
1
Brief Summary
The present clinico-biochemical study was carried out to estimate the levels of Fetuin A and MMP7 in serum of systemically healthy subjects in periodontal health and disease and to evaluate the impact of periodontal interventional therapy (scaling and root planing) on the same.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2017
CompletedFirst Submitted
Initial submission to the registry
February 26, 2019
CompletedFirst Posted
Study publicly available on registry
December 13, 2019
CompletedDecember 13, 2019
February 1, 2019
6 months
February 26, 2019
December 11, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
estimate the change in levels of Fetuin A and MMP7 in serum at baseline and 3 months post SRP
Serum was collected at baseline and 3 months and subjected to ELISA
Serum collection at baseline and 3 months
Secondary Outcomes (5)
Modified Gingival index (GI)
At baseline and 3 months
Relative Attachment level (RAL)
At baseline and 3 months
Probing Depth (PD)
At baseline and 3 months
Bleeding on Probing (BOP%)
At baseline and 3 months
Plaque index (PI)
At baseline and 3 months
Study Arms (3)
healthy
NO INTERVENTIONTen patients with clinically healthy gingiva with probing depth less than 3mm and less than or equal to 10% sites with gingival bleeding on probing present.
chronic gingivitis
NO INTERVENTIONChronic gingivitis was defined as having probing depth (PD) less than or equal to 4mm, relative attachment loss (RAL) ) less than or equal to 3mm and more than to 25% sites with gingival bleeding present (BOP)
chronic periodontitis
ACTIVE COMPARATORChronic periodontitis was defined as having probing depth more than or equal to 5mm, RAL more than or equal to 8mm, with more than or equal to 10% sites with BOP positive and evidence of bone loss determined radiographically. Non surgical periodontal therapy (SRP) was concluded in 3 months. Within the duration of the study, all subjects received supportive therapy
Interventions
Procedure/Surgery: non surgical periodontal therapy and root planing (SRP) was performed in two to four appointments lasting approximately 60 minutes each under local anaesthesia (2% lignocaine hydrochloride with 1:2,00,000 adrenaline) using area specific Gracey periodontal curettes and an ultrasonic device. The treatment was concluded in 3 months. Within the duration of the study, all subjects received supportive therapy, which included professional plaque control and reinstruction of oral hygiene.
Eligibility Criteria
You may qualify if:
- Age group of 30-39 years.
- Systemically healthy subjects.
- Patient who are co-operative and able to attend follow up.
- Patient who have not received any periodontal treatment within the past six months of baseline examination.
- Dentition with at least 20 functional teeth.
You may not qualify if:
- Medically compromised patients (history of diabetes mellitus, liver diseases, cardiovascular disease, kidney diseases, rheumatoid arthritis, bone diseases pulmonary disease, viral and fungal infections).
- Patients with calcification disorders (chronic kidney disease with vascular calcification, hyperparathyroidism, excessive intake of vitamin D, valvular calcific aortic stenosis
- Aggressive periodontitis.
- Bleeding disorders
- Gross oral pathology and suppuration
- Patients who had received antibiotic therapy and anti inflammatory within the last six months.
- Anomalies of the immune system.
- Pregnancy and lactation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Krishnadevaraya college of dental sciences
Bangalore, Karnataka, 562157, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
BV Karthikeyan, MDS
Krishnadevaraya college of Dental sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2019
First Posted
December 13, 2019
Study Start
March 10, 2017
Primary Completion
August 28, 2017
Study Completion
August 28, 2017
Last Updated
December 13, 2019
Record last verified: 2019-02